Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic
patients undergoing laparoscopic surgery after scheduled administration of intravenous
Ramosetron during hospital stays.
- Randomized controlled arm : Placebo versus Ramosetron injection
- Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs
after surgery